|
1
|
Schmale GA, Conrad EU III and Raskind WH:
The natural history of hereditary multiple exostoses. J Bone Joint
Surg Am. 76:986–992. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jennes I, Pedrini E, Zuntini M, Mordenti
M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L and
Wuyts W: Multiple osteochondromas: Mutation update and description
of the multiple osteochondromas mutation database (MOdb). Hum
Mutat. 30:1620–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tian C, Yan R, Wen S, Li X, Li T, Cai Z,
Du H and Chen H: A splice mutation and mRNA decay of EXT2 provoke
hereditary multiple exostoses. PLoS One. 9:e948482014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stieber JR and Dormans JP: Manifestations
of hereditary multiple exostoses. J Am Acad Orthop Surg. 13:110–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jamsheer A, Socha M, Sowińska-Seidler A,
Telega K, Trzeciak T and Latos-Bieleńska A: Mutational screening of
EXT1 and EXT2 genes in Polish patients with hereditary multiple
exostoses. J Appl Genet. 55:183–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vanita V, Sperling K, Sandhu HS, Sandhu PS
and Singh JR: Novel EXT1 and EXT2 mutations in hereditary multiple
exostoses families of Indian origin. Genet Test Mol Biomarkers.
13:43–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Y, Xing X, Xu S, Ma H, Cao L, Wang S
and Luo Y: Novel and recurrent mutations in the EXT1 and EXT2 genes
in Chinese kindreds with multiple osteochondromas. J Orthop Res.
31:1492–1499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones KB, Datar M, Ravichandran S, Jin H,
Jurrus E, Whitaker R and Capecchi MR: Toward an understanding of
the short bone phenotype associated with multiple osteochondromas.
J Orthop Res. 31:651–657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wuyts W and Van Hul W: Molecular basis of
multiple exostoses: Mutations in the EXT1 and EXT2 genes. Hum
Mutat. 15:220–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wuyts W, Radersma R, Storm K and Vits L:
An optimized DHPLC protocol for molecular testing of the EXT1 and
EXT2 genes in hereditary multiple osteochondromas. Clin Genet.
68:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lonie L, Porter DE, Fraser M, Cole T, Wise
C, Yates L, Wakeling E, Blair E, Morava E, Monaco AP and Ragoussis
J: Determination of the mutation spectrum of the EXT1/EXT2 genes in
British Caucasian patients with multiple osteochondromas, and
exclusion of six candidate genes in EXT negative cases. Hum Mutat.
27:11602006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCormick C, Leduc Y, Martindale D,
Mattison K, Esford LE, Dyer AP and Tufaro F: The putative tumour
suppressor EXT1 alters the expression of cell-surface heparan
sulfate. Nat Genet. 19:158–161. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zak BM, Crawford BE and Esko JD:
Hereditary multiple exostoses and heparan sulfate polymerization.
Biochim Biophys Acta. 1573:346–355. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahn J, Lüdecke HJ, Lindow S, Horton WA,
Lee B, Wagner MJ, Horsthemke B and Wells DE: Cloning of the
putative tumour suppressor gene for hereditary multiple exostoses
(EXT1). Nat Genet. 11:137–143. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stickens D, Clines G, Burbee D, Ramos P,
Thomas S, Hogue D, Hecht JT, Lovett M and Evans GA: The EXT2
multiple exostoses gene defines a family of putative tumour
suppressor genes. Nat Genet. 14:25–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Le Merrer M, Legeai-Mallet L, Jeannin PM,
Horsthemke B, Schinzel A, Plauchu H, Toutain A, Achard F, Munnich A
and Maroteaux P: A gene for hereditary multiple exostoses maps to
chromosome 19p. Hum Mol Genet. 3:717–722. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trebicz-Geffen M, Robinson D, Evron Z,
Glaser T, Fridkin M, Kollander Y, Vlodavsky I, Ilan N, Law KF,
Cheah KS, et al: The molecular and cellular basis of exostosis
formation in hereditary multiple exostoses. Int J Exp Pathol.
89:321–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pedrini E, De Luca A, Valente EM, Maini V,
Capponcelli S, Mordenti M, Mingarelli R, Sangiorgi L and
Dallapiccola B: Novel EXT1 and EXT2 mutations identified by DHPLC
in Italian patients with multiple osteochondromas. Hum Mutat.
26:2802005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarrión P, Sangorrin A, Urreizti R,
Delgado A, Artuch R, Martorell L, Armstrong J, Anton J, Torner F,
Vilaseca MA, et al: Mutations in the EXT1 and EXT2 genes in Spanish
patients with multiple osteochondromas. Sci Rep. 3:13462013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang XF, Xiang P, Chen J, Xing DJ, Huang
N, Min Q, Gu F, Tong Y, Pang CP, Qu J and Jin ZB: Targeted exome
sequencing identified novel USH2A mutations in Usher syndrome
families. PLoS One. 8:e638322013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu H, Wu S, Duan L, Zhu W, Zhang S, Hu X,
Jia W, Yang G, Liu C, Li W, et al: Identification of a novel EXT1
mutation in patients with hereditary multiple exostosis by exome
sequencing. Oncol Rep. 33:547–552. 2015.PubMed/NCBI
|
|
22
|
Wu J, Matthaei H, Maitra A, Dal Molin M,
Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, et
al: Recurrent GNAS mutations define an unexpected pathway for
pancreatic cyst development. Sci Transl Med. 3:92ra662011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Glusman G, Caballero J, Mauldin DE, Hood L
and Roach JC: Kaviar: An accessible system for testing SNV novelty.
Bioinformatics. 27:3216–3217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Porter DE, Lonie L, Fraser M, Dobson-Stone
C, Porter JR, Monaco AP and Simpson AH: Severity of disease and
risk of malignant change in hereditary multiple exostoses. A
genotype-phenotype study. J Bone Joint Surg Br. 86:1041–1046. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Francannet C, Cohen-Tanugi A, Le Merrer M,
Munnich A, Bonaventure J and Legeai-Mallet L: Genotype-phenotype
correlation in hereditary multiple exostoses. J Med Genet.
38:430–434. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alvarez CM, De Vera MA, Heslip TR and
Casey B: Evaluation of the anatomic burden of patients with
hereditary multiple exostoses. Clin Orthop Relat Res. 462:73–79.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McCormick C, Duncan G, Goutsos KT and
Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a
stable complex that accumulates in the Golgi apparatus and
catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA.
97:668–4073. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Esko JD and Lindahl U: Molecular diversity
of heparan sulfate. J Clin Invest. 108:169–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jones KB, Pacifici M and Hilton MJ:
Multiple hereditary exostoses (MHE): Elucidating the pathogenesis
of a rare skeletal disorder through interdisciplinary research.
Connect Tissue Res. 55:80–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koziel L, Kunath M, Kelly OG and Vortkamp
A: Ext1-dependent heparan sulfate regulates the range of Ihh
signaling during endochondral ossification. Dev Cell. 6:801–813.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anower-E-Khuda MF, Matsumoto K, Habuchi H,
Morita H, Yokochi T, Shimizu K and Kimata K: Glycosaminoglycans in
the blood of hereditary multiple exostoses patients: Half reduction
of heparan sulfate to chondroitin sulfate ratio and the possible
diagnostic application. Glycobiology. 23:865–876. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jochmann K, Bachvarova V and Vortkamp A:
Reprint of: Heparan sulfate as a regulator of endochondral
ossification and osteochondroma development. Matrix Biol.
35:239–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gerards M, van den Bosch B, Calis C,
Schoonderwoerd K, van Engelen K, Tijssen M, De Coo R, van der Kooi
A and Smeets H: Nonsense mutations in CABC1/ADCK3 cause progressive
cerebellar ataxia and atrophy. Mitochondrion. 10:510–515. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Inoue K, Khajavi M, Ohyama T, Hirabayashi
S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner
M and Lupski JR: Molecular mechanism for distinct neurological
phenotypes conveyed by allelic truncating mutations. Nat Genet.
36:361–369. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang F, Liang J, Guo X, Zhang Y, Wen Y,
Li Q, Zhang Z, Ma W, Dai L, Liu X, et al: Exome sequencing and
functional analysis identifies a novel mutation in EXT1 gene that
causes multiple osteochondromas. PLoS One. 8:e723162013. View Article : Google Scholar : PubMed/NCBI
|
